U.S., April 16 -- An application to own the trademark for 'IBDIQ' has been filed on Jun. 04, 2024.
Owner(s):
Takeda Pharmaceuticals U.S.A., Inc.; 500 Kendall Street, , Massachusetts
Goods and/or Services:
For: Healthcare provider and medical professional support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve the understanding of healthcare providers and medical professionals about inflammatory bowel disease (IBD) and pharmaceutical treatment thereof
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-15&serialNumber=98584115
Disclaimer: Curated by HT Syndica...